New research has found a significant link between anticholinergic drugs – including common antidepressants– and risk of dementia in the long term. Daily use of one of these drugs for three consecutive years or more increased the likelihood of a dementia diagnosis, particularly for middle-aged and elderly patients. Anticholinergic drugs […]
The consumer genetics company 23andMe is teaming up with the UK drug giant GlaxoSmithKline to develop new drugs. As part of a four-year collaboration, GSK is committing $US300 million to 23andMe and, using 23andMe’s data, working on an experimental drug to treat Parkinson’s disease. The move comes shortly after GSK […]
Following is a transcript of the video. This device can calm symptoms of Parkinson’s disease. It’s called Deep Brain Stimulation therapy. A surgically implanted device delivers electrical stimulation to the brain. It targets specific areas of the brain to help patients regain control of their bodies. Parkinson’s patients can suffer […]
BlueRock Therapeutics is a...
